Veterinary Medicines

Zylexis lyofilizát a riedidlo na injekčnú suspenziu pre psov, mačky, kone, hovädzí dobytok a ošípané

Authorised
  • Orf virus, strain D1701, Inactivated
Download as PDF

Product identification

Medicine name:
Zylexis lyofilizát a riedidlo na injekčnú suspenziu pre psov, mačky, kone, hovädzí dobytok a ošípané
Active substance:
  • Orf virus, strain D1701, Inactivated
Target species:
  • Dog
  • Cat
  • Cattle
  • Horse
  • Pig
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Orf virus, strain D1701, Inactivated
    1.00
    relative potency
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
    • Horse
      • All relevant tissues
        0
        day
    • Pig
      • All relevant tissues
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QL03AX
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Ceska Republika s.r.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium SA
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/021/05-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 8/07/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."